| ISIN | LU2041628590 | 
|---|---|
| Valor Number | 49478901 | 
| Bloomberg Global ID | |
| Fund Name | JSS Sustainable Equity - Future Health M USD acc | 
| Fund Provider | 
                                            
                                            
                                            J. Safra Sarasin Investmentfonds AG
                                            
    
        Basel, Switzerland Phone: +41 58 317 44 44 Web: www.jsafrasarasin.com  | 
                                    
| Fund Provider | J. Safra Sarasin Investmentfonds AG | 
| Representative in Switzerland | 
                                            J. Safra Sarasin Investmentfonds AG Basel Phone: +41 58 317 44 00  | 
                                    
| Distributor(s) | 
                                            
                                                Bank J. Safra Sarasin AG Basel Phone: +41 58 317 44 00  | 
                                    
| Asset Class | Equities | 
| EFC Category | |
| Distribution Policy | Accumulation | 
| Home Country | Luxembourg | 
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) | 
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) | 
| Investment Strategy *** | The investment objective of the fund is to achieve long-term capital growth. The Reference Currency of the Sub-Fund is the US Dollar (USD). The assets of the fund are mainly invested worldwide either directly (min. 67% of the SubFund’s assets) or indirectly in equity securities that offer an exposure to one or multiple emerging and transformational health trends. The Sub-Fund invests in leading companies and niche players whose products and services contribute to the improvement of health outcome and the dampening of rising healthcare costs. | 
| Peculiarities | 
| Current Price * | 103.38 USD | 29.04.2024 | 
|---|---|---|
| Previous Price * | 102.98 USD | 26.04.2024 | 
| 52 Week High * | 110.74 USD | 08.05.2023 | 
| 52 Week Low * | 87.01 USD | 27.10.2023 | 
| NAV * | 103.38 USD | 29.04.2024 | 
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 135,372,697 | |
| Unit/Share Assets *** | 190,559 | |
| Trading Information SIX | ||
| YTD Performance | - | - | 
|---|---|---|
| YTD Performance (in CHF) | - | - | 
| 1 month | -0.04% | 
        02.04.2024 - 29.04.2024
        02.04.2024 29.04.2024  | 
                                    
| 3 months | +0.49% | 
        29.01.2024 - 29.04.2024
        29.01.2024 29.04.2024  | 
                                    
| 6 months | +18.43% | 
        30.10.2023 - 29.04.2024
        30.10.2023 29.04.2024  | 
                                    
| 1 year | -4.97% | 
        02.05.2023 - 29.04.2024
        02.05.2023 29.04.2024  | 
                                    
| 2 years | +3.38% | 
        14.09.2022 - 29.04.2024
        14.09.2022 29.04.2024  | 
                                    
| 3 years | - | - | 
| 5 years | - | - | 
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Johnson & Johnson | 8.00% | |
|---|---|---|
| Eli Lilly and Co | 7.24% | |
| Danaher Corp | 6.45% | |
| Sanofi SA | 6.21% | |
| argenx SE | 5.71% | |
| Boston Scientific Corp | 4.87% | |
| AbbVie Inc | 4.65% | |
| Fresenius SE & Co KGaA | 4.63% | |
| Merck & Co Inc | 4.63% | |
| Lonza Group Ltd | 4.45% | |
| Last data update | 30.09.2025 | |
| TER | 0.40% | 
|---|---|
| TER date | 31.10.2024 | 
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.12% | 
| Ongoing Charges *** | 0.25% | 
| 
                                            SRRI ***
                                             | 
                                    |
| SRRI date *** | 30.04.2024 |